Skip to main content
Van Morris, MD, Oncology, Houston, TX

VanMorrisMD

Oncology Houston, TX

Gastrointestinal Cancer, Hematologic Oncology

MD

Dr. Morris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Morris' full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2008 - 2011
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • WA State Medical License
    WA State Medical License 2023 - 2025
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • TN State Medical License
    TN State Medical License 2023 - 2024
  • GA State Medical License
    GA State Medical License 2023 - 2024
  • TX State Medical License
    TX State Medical License 2012 - 2024
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-Challenge  
    B Kee, N Garg, M J Overman, V K Morris, B Johnson, J Wu, J H Strickler, S Kopetz, X Liu, D S Hong, Annals of Oncology

Lectures

  • NRG-GI005 (COBRA): Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
  • Are We Moving the Needle in Advanced Colorectal and Anal Cancers? 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

  • Timely Surveillance with Chest Imaging May Benefit Colorectal Cancer Patients
    Timely Surveillance with Chest Imaging May Benefit Colorectal Cancer PatientsOctober 16th, 2022
  • MD Anderson Receives over $31 Million in CPRIT Funding
    MD Anderson Receives over $31 Million in CPRIT FundingFebruary 16th, 2022
  • February eGuide
    February eGuideFebruary 2nd, 2022
  • Join now to see all

Professional Memberships